FDA Inspection
Sanofi Winthrop IndustrieSanofi Winthrop Industrie – FDA Inspection, Nov 17, 2023
Record Details
This FDA Inspection record concerns Sanofi Winthrop Industrie, with an inspection on November 17, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · b6dae7b6-1de5-4a55-90f3-3f14c11e72eb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1223859
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Sanofi Winthrop Industrie
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 26, 2024 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 18, 2020 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 13, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 28, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Sanofi Winthrop Industrie
- FDA Inspection 1227792 - 2024-01-26
- FDA Inspection 1120933 - 2020-02-18
- FDA Inspection 1059004 - 2018-07-13
- FDA Inspection 994790 - 2016-07-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.